Tandem Diabetes Care, Inc.
TNDM
$10.99
$0.171.57%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 25.84% | 27.65% | 25.74% | 10.75% | 0.72% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 25.84% | 27.65% | 25.74% | 10.75% | 0.72% |
| Cost of Revenue | 17.23% | 20.25% | 18.58% | 12.43% | 5.11% |
| Gross Profit | 34.79% | 35.28% | 33.15% | 9.10% | -3.48% |
| SG&A Expenses | 19.49% | 18.75% | 14.48% | 10.03% | 2.57% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.82% | 18.76% | 16.75% | 12.24% | 5.78% |
| Operating Income | 34.10% | 31.94% | 30.43% | -22.61% | -47.64% |
| Income Before Tax | -54.14% | -28.07% | 58.29% | 39.92% | 40.76% |
| Income Tax Expenses | -41.27% | 79.53% | 76.28% | 5.35% | 85.50% |
| Earnings from Continuing Operations | -50.52% | -29.98% | 56.86% | 39.18% | 39.19% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -50.52% | -29.98% | 56.86% | 39.18% | 39.19% |
| EBIT | 34.10% | 31.94% | 30.43% | -22.61% | -47.64% |
| EBITDA | 39.26% | 36.77% | 34.90% | -25.13% | -54.65% |
| EPS Basic | -47.67% | -28.22% | 57.18% | 39.76% | 39.84% |
| Normalized Basic EPS | 29.06% | 32.15% | 33.44% | -21.33% | -50.86% |
| EPS Diluted | -47.67% | -28.22% | 57.18% | 39.76% | 39.84% |
| Normalized Diluted EPS | 29.05% | 32.14% | 33.43% | -21.33% | -50.86% |
| Average Basic Shares Outstanding | 1.58% | 0.86% | 0.74% | 0.91% | 1.09% |
| Average Diluted Shares Outstanding | 1.67% | 0.94% | 0.83% | 0.91% | 1.09% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |